Ziprasidone and anxiety Patient Reports February 11, 2012

Ziprasidone Side Effects Report #4770754-3
Ziprasidone side effect was reported by a Physician from ITALY on Feb 16, 2005. Male patient, 47 years of age, weighting 242.5 lb, was diagnosed with schizophrenia and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: adverse event, anxiety , hallucination. Ziprasidone dosage: 140 MG (BID), ORAL. During the same period patient was treated with LORAZEPAM, TELMISARTAN. Patient was hospitalized. Patient recovered.

Ziprasidone Side Effects Report #4937133-7
Ziprasidone side effect was reported by a Physician from ITALY on Feb 14, 2006. Male patient, 45 years of age, weighting 220.5 lb, was diagnosed with schizophrenia and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: anxiety , disease progression, hypochondriasis, hypomania, insomnia, logorrhoea, psychomotor hyperactivity, psychotic disorder , thinking abnormal. Ziprasidone dosage: 160 MG (80 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.

Ziprasidone Side Effects Report #4553428-3
Ziprasidone side effect was reported by a Physician from on July 27, 2004. Male patient, 25 years of age, weighting 110.2 lb, was diagnosed with schizophrenia and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: aggression, akathisia, anxiety , insomnia, muscle rigidity, psychomotor hyperactivity. Ziprasidone dosage: 40 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with RISPERDAL, BIPERIDEN. Patient was hospitalized. Patient recovered.

Ziprasidone Side Effects Report #5129390-1
Ziprasidone side effect was reported by a Physician from TURKEY on Sept 29, 2006. Male patient, 23 years of age, was diagnosed with schizophrenia and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: anxiety , obsessive-compulsive disorder . Ziprasidone dosage: 120 MG. During the same period patient was treated with OLANZAPINE. Patient recovered.


Ziprasidone Side Effects Report #4553425-8
Ziprasidone side effect was reported by a Physician from on July 23, 2004. Male patient, 21 years of age, weighting 149.9 lb, was diagnosed with schizophrenia and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: agitation, akathisia, anxiety , delirium, homicidal ideation, hyperhidrosis, impulse-control disorder, incontinence, insomnia. Ziprasidone dosage: 100 MG (1 IN 1 D), ORAL. During the same period patient was treated with CLONAZEPAM. Patient was hospitalized. Patient recovered.

Ziprasidone Side Effects Report #5399150-5
Ziprasidone side effect was reported by a Pharmacist from UNITED STATES on July 25, 2007. Male patient, weighting 322.0 lb, was diagnosed with schizoaffective disorder and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: akathisia, anxiety , dysphagia, tardive dyskinesia. Ziprasidone dosage: 160MG QHS PO. Patient was hospitalized. Patient recovered.

Ziprasidone Side Effects Report #4709046-7
Ziprasidone side effect was reported by a Health Professional from SPAIN on June 20, 2005. Female patient, 57 years of age, was diagnosed with ill-defined disorder and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: anxiety , blood pressure increased, electrocardiogram qt corrected interval prolonged, heart rate increased, intentional misuse, overdose, oxygen saturation decreased, somnolence, tremor. Ziprasidone dosage: 160 MG (1 D). During the same period patient was treated with FLUNITRAZEPAM, PAROXETINE, LORAZEPAM. Patient recovered.

Ziprasidone Side Effects Report #4817568-3
Ziprasidone side effect was reported by a Physician from SPAIN on Oct 10, 2005. Female patient, 57 years of age, was diagnosed with bipolar ii disorder, ill-defined disorder and was treated with Ziprasidone. After drug was administered, patient experienced the following side effects: anxiety , blood pressure increased, coma, electrocardiogram qt corrected interval prolonged, heart rate increased, intentional overdose, oxygen saturation decreased, poisoning , somnolence. Ziprasidone dosage: 160 MG (2 IN 1 D), ORAL. During the same period patient was treated with CLOMETHIAZOLE, FLUNITRAZEPAM, PAROXETINE, LORAZEPAM, PICOSULPHATE. Patient was hospitalized. Patient recovered.